
1. med microbiol immunol. 2016 jun;205(3):201-8. doi: 10.1007/s00430-016-0451-4.
epub 2016 mar 2.

eradication measles: remaining challenges.

holzmann h(1), hengel h(2), tenbusch m(3), doerr hw(4).

author information: 
(1)department virology, medical university vienna, vienna, austria.
heidemarie.holzmann@meduniwien.ac.at.
(2)institute virology, university medical center, albert-ludwigs-university
freiburg, freiburg, germany.
(3)department molecular medical virology, ruhr-university bochum, bochum, 
germany.
(4)institute medical virology, goethe-university hospital frankfurt,
frankfurt/m., germany.

measles virus (mev) aerosol-borne one contagious pathogenic
viruses known. almost every mev infection becomes clinically manifest can
lead serious even fatal complications, especially conditions of
malnutrition developing countries, still 115,000 160,000 patients die
from measles every year. specific antiviral treatment. addition,
mev infections cause long-lasting memory b cell impairment, predisposing
people susceptible opportunistic infections years. rare, fatal
long-term consequence measles subacute sclerosing panencephalitis. fifteen 
years ago (2001), launched programme eliminate measles a
worldwide vaccination strategy. promising, mev a
human-specific morbillivirus (i.e. without relevant animal reservoir), safe and
potent vaccine viruses sufficiently produced since decades common
application, millions vaccine doses used globally without any
indications safety efficacy issues. though prevalence wild-type mev
infection decreased >90 % europe, measles still eliminated and
has even re-emerged recurrent outbreaks developed countries, which
effective vaccination programmes installed decades. here, discuss
the crucial factors worldwide elimination mev: (1) efficacy current
vaccines, (2) extremely high contagiosity mev demanding >95 %
vaccination rate based two doses avoid primary vaccine failure well as
the installation catch-up vaccination programmes fill immunity gaps 
achieve herd immunity, (3) implications sporadic cases secondary
vaccine failure, (4) organisation, acceptance drawbacks modern vaccination
campaigns, (5) waning public attention measles, increasing concerns from
vaccine-associated adverse reactions societies high socio-economic
standards (6) clinical, epidemiological virological surveillance the
use modern laboratory diagnostics reporting systems. consequent
implementation carefully designed epidemiologic prophylactic measures, 
should possible eradicate mev globally mankind, closely
related morbillivirus rinderpest could successfully eliminated the
cattle global scale.

doi: 10.1007/s00430-016-0451-4 
pmcid: pmc4866980
pmid: 26935826  [indexed medline]

